Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease

NCT04765423 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Poor patient accrual

Conditions

Malignant Neoplasm of Prostate

Interventions

DEVICE: [F-18] NaF PET/CT
DEVICE: [F-18] fluciclovine PET/CT

Sponsor

Case Comprehensive Cancer Center